Overview

Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study

Status:
Completed
Trial end date:
2019-02-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an early goal-directed decrement of preload and afterload with a target systolic blood pressure of 90-110 mmHg by aggressive vasodilatation in patients with acute HF in the non-ICU setting is safe, and leads to a better clinical and economical outcome
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Treatments:
Candesartan cilexetil
Nitroglycerin